APA (7th ed.) Citation

Yao, H., Ren, S., Wang, L., Ren, M., Cai, J., Chen, D., . . . Fan, F. (2025). BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: A single-center, single-arm, phase 1 trial. Journal of Hematology & Oncology, 18(1), 1. https://doi.org/10.1186/s13045-025-01713-2

Chicago Style (17th ed.) Citation

Yao, Hao, et al. "BCMA/GPRC5D Bispecific CAR T-cell Therapy for Relapsed/refractory Multiple Myeloma with Extramedullary Disease: A Single-center, Single-arm, Phase 1 Trial." Journal of Hematology & Oncology 18, no. 1 (2025): 1. https://doi.org/10.1186/s13045-025-01713-2.

MLA (9th ed.) Citation

Yao, Hao, et al. "BCMA/GPRC5D Bispecific CAR T-cell Therapy for Relapsed/refractory Multiple Myeloma with Extramedullary Disease: A Single-center, Single-arm, Phase 1 Trial." Journal of Hematology & Oncology, vol. 18, no. 1, 2025, p. 1, https://doi.org/10.1186/s13045-025-01713-2.